Annual Operating Expenses
$30.18 B
+$1.47 B+5.12%
31 December 2023
Summary:
Pfizer annual total operating expenses is currently $30.18 billion, with the most recent change of +$1.47 billion (+5.12%) on 31 December 2023. During the last 3 years, it has risen by +$5.84 billion (+24.02%). PFE annual operating expenses is now -10.75% below its all-time high of $33.82 billion, reached on 31 December 2010.PFE Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$7.15 B
-$566.00 M-7.33%
30 September 2024
Summary:
Pfizer quarterly total operating expenses is currently $7.15 billion, with the most recent change of -$566.00 million (-7.33%) on 30 September 2024. Over the past year, it has dropped by -$17.00 million (-0.24%). PFE quarterly operating expenses is now -28.49% below its all-time high of $10.00 billion, reached on 31 December 2008.PFE Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.1% | -0.2% |
| 3 y3 years | +24.0% | +9.3% |
| 5 y5 years | +20.2% | +5.9% |
PFE Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +24.0% | -23.8% | +24.9% |
| 5 y | 5 years | at high | +24.0% | -23.8% | +41.3% |
| alltime | all time | -10.8% | +1758.6% | -28.5% | +876.5% |
Pfizer Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.15 B(-7.3%) |
| June 2024 | - | $7.72 B(+5.8%) |
| Mar 2024 | - | $7.30 B(-15.7%) |
| Dec 2023 | $30.18 B(+5.1%) | $8.66 B(+20.7%) |
| Sept 2023 | - | $7.17 B(-2.2%) |
| June 2023 | - | $7.33 B(+4.3%) |
| Mar 2023 | - | $7.03 B(-25.2%) |
| Dec 2022 | $28.71 B(+7.3%) | $9.39 B(+35.9%) |
| Sept 2022 | - | $6.91 B(+3.4%) |
| June 2022 | - | $6.68 B(+16.7%) |
| Mar 2022 | - | $5.73 B(-32.7%) |
| Dec 2021 | $26.76 B(+10.0%) | $8.51 B(+29.9%) |
| Sept 2021 | - | $6.55 B(+7.7%) |
| June 2021 | - | $6.08 B(+8.0%) |
| Mar 2021 | - | $5.63 B(-28.3%) |
| Dec 2020 | $24.34 B(-4.7%) | $7.85 B(+34.9%) |
| Sept 2020 | - | $5.82 B(+3.8%) |
| June 2020 | - | $5.61 B(+10.7%) |
| Mar 2020 | - | $5.06 B(-16.0%) |
| Dec 2019 | $25.54 B(+1.7%) | $6.03 B(-10.8%) |
| Sept 2019 | - | $6.75 B(+3.3%) |
| June 2019 | - | $6.54 B(+5.0%) |
| Mar 2019 | - | $6.22 B(+13.8%) |
| Dec 2018 | $25.11 B(-7.8%) | $5.47 B(-19.0%) |
| Sept 2018 | - | $6.75 B(+3.4%) |
| June 2018 | - | $6.53 B(+2.8%) |
| Mar 2018 | - | $6.35 B(-21.2%) |
| Dec 2017 | $27.25 B(+1.7%) | $8.06 B(+23.1%) |
| Sept 2017 | - | $6.55 B(+1.9%) |
| June 2017 | - | $6.42 B(+3.3%) |
| Mar 2017 | - | $6.22 B(-23.1%) |
| Dec 2016 | $26.79 B(+2.2%) | $8.08 B(+26.2%) |
| Sept 2016 | - | $6.41 B(+3.7%) |
| June 2016 | - | $6.18 B(+0.9%) |
| Mar 2016 | - | $6.12 B(-26.9%) |
| Dec 2015 | $26.23 B(-1.1%) | $8.38 B(+41.3%) |
| Sept 2015 | - | $5.93 B(-1.1%) |
| June 2015 | - | $5.99 B(+1.1%) |
| Mar 2015 | - | $5.93 B(-27.2%) |
| Dec 2014 | $26.53 B(+3.5%) | $8.14 B(+28.6%) |
| Sept 2014 | - | $6.33 B(+0.8%) |
| June 2014 | - | $6.28 B(+8.7%) |
| Mar 2014 | - | $5.78 B(-18.4%) |
| Dec 2013 | $25.63 B(-7.7%) | $7.09 B(+15.4%) |
| Sept 2013 | - | $6.14 B(-1.9%) |
| June 2013 | - | $6.26 B(+1.9%) |
| Mar 2013 | - | $6.15 B(-18.9%) |
| Dec 2012 | $27.76 B(-12.5%) | $7.58 B(+15.0%) |
| Sept 2012 | - | $6.59 B(+0.7%) |
| June 2012 | - | $6.54 B(-12.2%) |
| Mar 2012 | - | $7.45 B(-0.2%) |
| Dec 2011 | $31.73 B(-6.2%) | $7.47 B(-6.9%) |
| Sept 2011 | - | $8.02 B(-4.7%) |
| June 2011 | - | $8.41 B(+5.6%) |
| Mar 2011 | - | $7.97 B(+6.5%) |
| Dec 2010 | $33.82 B(+33.1%) | $7.49 B(-24.9%) |
| Sept 2010 | - | $9.96 B(+19.6%) |
| June 2010 | - | $8.33 B(+3.7%) |
| Mar 2010 | - | $8.04 B(-11.5%) |
| Dec 2009 | $25.40 B(-11.1%) | $9.08 B(+66.0%) |
| Sept 2009 | - | $5.47 B(-3.2%) |
| June 2009 | - | $5.65 B(+10.7%) |
| Mar 2009 | - | $5.10 B(-49.0%) |
| Dec 2008 | $28.59 B(+6.5%) | $10.00 B(+65.9%) |
| Sept 2008 | - | $6.03 B(-9.3%) |
| June 2008 | - | $6.65 B(+9.7%) |
| Mar 2008 | - | $6.06 B(-21.0%) |
| Dec 2007 | $26.84 B(+1.5%) | $7.67 B(+17.2%) |
| Sept 2007 | - | $6.54 B(-3.7%) |
| June 2007 | - | $6.79 B(+16.3%) |
| Mar 2007 | - | $5.84 B(-25.0%) |
| Dec 2006 | $26.45 B | $7.79 B(+20.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $6.45 B(+0.1%) |
| June 2006 | - | $6.45 B(+11.9%) |
| Mar 2006 | - | $5.76 B(-19.4%) |
| Dec 2005 | $25.97 B(-0.8%) | $7.15 B(+17.3%) |
| Sept 2005 | - | $6.10 B(-5.5%) |
| June 2005 | - | $6.45 B(-4.1%) |
| Mar 2005 | - | $6.73 B(+10.5%) |
| Dec 2004 | $26.17 B(+5.6%) | $6.09 B(-10.0%) |
| Sept 2004 | - | $6.77 B(-2.0%) |
| June 2004 | - | $6.91 B(+7.8%) |
| Mar 2004 | - | $6.41 B(-20.3%) |
| Dec 2003 | $24.78 B(+54.3%) | $8.03 B(+24.1%) |
| Sept 2003 | - | $6.48 B(+7.0%) |
| June 2003 | - | $6.05 B(+52.6%) |
| Mar 2003 | - | $3.97 B(-12.0%) |
| Dec 2002 | $16.06 B(+10.1%) | $4.51 B(+15.4%) |
| Sept 2002 | - | $3.90 B(-0.3%) |
| June 2002 | - | $3.92 B(+5.0%) |
| Mar 2002 | - | $3.73 B(+12.9%) |
| Dec 2001 | $14.59 B(-7.5%) | $3.30 B(-13.2%) |
| Sept 2001 | - | $3.81 B(-3.6%) |
| June 2001 | - | $3.95 B(+8.7%) |
| Mar 2001 | - | $3.63 B(-16.0%) |
| Dec 2000 | $15.78 B(+0.2%) | $4.33 B(+16.9%) |
| Sept 2000 | - | $3.70 B(-6.0%) |
| June 2000 | - | $3.94 B(-3.2%) |
| Mar 2000 | - | $4.06 B(-6.1%) |
| Dec 1999 | $15.75 B(+15.3%) | $4.33 B(+15.5%) |
| Sept 1999 | - | $3.74 B(+0.5%) |
| June 1999 | - | $3.73 B(+58.3%) |
| Mar 1999 | - | $2.35 B(-69.6%) |
| Dec 1998 | $13.66 B(+106.0%) | $7.75 B(+278.3%) |
| Sept 1998 | - | $2.05 B(-0.1%) |
| June 1998 | - | $2.05 B(+14.1%) |
| Mar 1998 | - | $1.80 B(-6.0%) |
| Dec 1997 | $6.63 B(+14.7%) | $1.91 B(+17.6%) |
| Sept 1997 | - | $1.63 B(-11.4%) |
| June 1997 | - | $1.84 B(+11.9%) |
| Mar 1997 | - | $1.64 B(+40.9%) |
| Dec 1996 | $5.79 B(+2.0%) | $1.17 B(-24.7%) |
| Sept 1996 | - | $1.55 B(-7.4%) |
| June 1996 | - | $1.67 B(+14.4%) |
| Mar 1996 | - | $1.46 B(-9.3%) |
| Dec 1995 | $5.67 B(+21.1%) | $1.61 B(+17.5%) |
| Sept 1995 | - | $1.37 B(-4.3%) |
| June 1995 | - | $1.43 B(+7.2%) |
| Mar 1995 | - | $1.34 B(+0.5%) |
| Dec 1994 | $4.68 B(-7.3%) | $1.33 B(+14.3%) |
| Sept 1994 | - | $1.16 B(+2.8%) |
| June 1994 | - | $1.13 B(+7.1%) |
| Mar 1994 | - | $1.06 B(-45.2%) |
| Dec 1993 | $5.05 B(+25.4%) | $1.93 B(+83.2%) |
| Sept 1993 | - | $1.05 B(+28.1%) |
| June 1993 | - | $821.00 M(-19.4%) |
| Mar 1993 | - | $1.02 B(-10.1%) |
| Dec 1992 | $4.03 B(+7.7%) | $1.13 B(+16.8%) |
| Sept 1992 | - | $969.50 M(-2.1%) |
| June 1992 | - | $989.90 M(+6.2%) |
| Mar 1992 | - | $932.20 M(-10.0%) |
| Dec 1991 | $3.74 B(+12.7%) | $1.04 B(+13.0%) |
| Sept 1991 | - | $916.90 M(-1.2%) |
| June 1991 | - | $928.00 M(+8.0%) |
| Mar 1991 | - | $859.10 M(-12.0%) |
| Dec 1990 | $3.32 B(+16.5%) | $976.80 M(+22.3%) |
| Sept 1990 | - | $798.60 M(-1.4%) |
| June 1990 | - | $810.20 M(+10.6%) |
| Mar 1990 | - | $732.60 M |
| Dec 1989 | $2.85 B(+11.8%) | - |
| Dec 1988 | $2.55 B(+13.5%) | - |
| Dec 1987 | $2.24 B(+15.5%) | - |
| Dec 1986 | $1.94 B(+12.4%) | - |
| Dec 1985 | $1.73 B(+6.4%) | - |
| Dec 1984 | $1.62 B | - |
FAQ
- What is Pfizer annual total operating expenses?
- What is the all time high annual operating expenses for Pfizer?
- What is Pfizer annual operating expenses year-on-year change?
- What is Pfizer quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Pfizer?
- What is Pfizer quarterly operating expenses year-on-year change?
What is Pfizer annual total operating expenses?
The current annual operating expenses of PFE is $30.18 B
What is the all time high annual operating expenses for Pfizer?
Pfizer all-time high annual total operating expenses is $33.82 B
What is Pfizer annual operating expenses year-on-year change?
Over the past year, PFE annual total operating expenses has changed by +$1.47 B (+5.12%)
What is Pfizer quarterly total operating expenses?
The current quarterly operating expenses of PFE is $7.15 B
What is the all time high quarterly operating expenses for Pfizer?
Pfizer all-time high quarterly total operating expenses is $10.00 B
What is Pfizer quarterly operating expenses year-on-year change?
Over the past year, PFE quarterly total operating expenses has changed by -$17.00 M (-0.24%)